slot online games

slot online games 。

Abandoned mines in the US pose dangers to people and property when land gives way

2024 was a banner year for podcasts, with three major new additions, two of which are now among my favorites of all time. My listening habits haven't changed too much year-over-year. I still use Pocket Casts, which is available everywhere and syncs my listening position in episodes reliably. It's free on mobile and web, but it looks like you have to pay for a subscription to access the app on desktop or wearables now. I paid for this service across all supported platforms years ago, but I usually just use the mobile app. My wife listens to podcasts with Spotify, which I guess I get though I feel very strongly that podcasts are not music, and I don't like seeing the two mixed in a single app. I subscribed to Wondery+ last January because I like their content and have binged-listened to many of their shows over time, including several that don't make the list this year because I finished them in the past. But I will let it go when the subscription ends this coming month, as I didn't use it as much as I'd expected. The collection of podcasts I subscribe to is still a mix of shows I listen to religiously and those that I cherry-pick episodes with specific topics. 📃The podcasts I subscribe to I subscribe to the following podcasts: American Story Tellers American Scandal Behind the Tech with Kevin Scott CDMX Expats The Earful Tower: Paris Hanselminutes with Scott Hanselman If Books Could Kill ⭐ Made by Google Maintenance Phase .NET Rocks! ⭐ No Such Podcast The Rewatchables ⭐ Rolling Stone Music Now RunAsRadio ⭐ Scott & Mark Learn to... ⭐ Sync Up by Microsoft 365 Talks at Google That Chapter Podcast 🕒My top podcasts by listening time According to Pocket Casts, my top five podcasts of 2024 by listening time are: The Rewatchables If Books Could Kill .NET Rocks! American Scandal That Chapter Podcast 🆕New podcasts of 2024 As noted up top, I added three podcasts to Pocket Casts this past year, and each is notable because they're all binge-listens in that I will, in time, listen to every episode they make. They are: The Rewatchables Scott & Mark Learn to... No Such Podcast But the first two, The Rewatchables and Scott & Mark Learn to..., are even more notable because they have instantly catapulted to the top of my lists of favorite podcasts. They're both terrific. On that note... 💖My favorite bingeable podcasts of 2024 Sometimes you find a podcast that is so good that you go back and listen to every single episode from the past and then listen immediately to new episodes when they appear. One early example of this for me was How Did This Get Made?, though I found myself listening less and less a decade later and then finally unsubscribed this past year. But I still have a few similar go-to's, including the two noted above, that are new to 2024. That's amazing to me. In order, they are: ⭐The Rewatchable... With technology shaping our everyday lives, how could we not dig deeper? Thurrott Premium delivers an honest and thorough perspective about the technologies we use and rely on everyday. Discover deeper content as a Premium member. Paul Thurrott is an award-winning technology journalist and blogger with 30 years of industry experience and the author of 30 books. He is the owner of and the host of three tech podcasts: with Leo Laporte and Richard Campbell, , and with Brad Sams. He was formerly the senior technology analyst at Windows IT Pro and the creator of the SuperSite for Windows from 1999 to 2014 and the Major Domo of Thurrott.com while at BWW Media Group from 2015 to 2023. You can reach Paul via , or . Join the crowd where the love of tech is real - become a Thurrott Premium Member today! Sign up for our new free newsletter to get three time-saving tips each FridayMONTRÉAL , Nov. 25, 2024 /PRNewswire/ -- Workleap , a leading Canadian software company behind products that empower 20,000 companies in more than 100 countries to build better employee experiences, announces its fall platform release introducing new solutions and integrated features into an all-in-one simple-to-use platform. This release marks a new milestone in Workleap's ongoing commitment to transform the employee experience by empowering HR leaders to drive organizational performance and achieve business goals. Workleap's comprehensive platform helps HR lead organizations to thrive in the modern setting of hybrid, remote, and distributed work environments. The consolidated solution for understanding employee engagement, driving performance, and developing employees is the best add-on to your existing HRIS and HR technology, allowing companies to add simple experiences across the employee lifecycle. Bringing these functions together in one platform, Workleap enables HR professionals to create a more responsive, agile and employee-centric work environment. What's New Why It Matters " Hybrid work has completely reshaped the role of HR. It's no longer just about managing employees—it's about building the right frameworks, fostering authentic connections, and leveraging tools that drive meaningful outcomes," said Simon De Baene , Co-founder and CEO of Workleap. "At Workleap, our mission is clear: make work simpler. The Workleap platform brings together the tools HR teams and leaders need to focus on what matters most—creating workplaces where people feel supported, connected, and empowered to grow. By continuing to invest in our platform, we're accelerating innovation with solutions like Workleap Performance—designed to be simple, effective, and built to keep HR and leaders ahead as the future of work evolves." To learn more about Workleap's employee experience platform, visit workleap.com . About Workleap Workleap is the best add-on to your HRIS to build better employee experiences. The all-in-one Workleap platform empowers organizations to make work simpler by unifying onboarding, engagement, performance, and development —in one platform. Workleap is a Montréal, Canada-based company building the operating system for hybrid work—unifying the experience to streamline talent management and scale productivity tools across 20,000 companies in more than 100 countries. Media Contact Jaclyn Pullen PANBlast for Workleap workleap@panblastpr.com View original content to download multimedia: https://www.prnewswire.com/news-releases/workleap-fall-launch-empowering-hr-leaders-with-new-features-for-employee-growth-and-engagement-302315807.html SOURCE WorkleapSignals Market Expansion in the State of Texas ADDISON, Texas, Dec. 16, 2024 /PRNewswire/ -- Solis Mammography , the nation's largest independent provider of specialized breast health services, has announced its entry into the third largest metropolitan area in Texas with its most recent acquisition of Avestēe Women's Imaging Centers in San Antonio. Avestēe is known for its state-of-the-art imaging expertise and its beautiful and calming patient environment. With Avestēe's six imaging locations, Solis Mammography now has a presence in the major metropolitan areas of Texas, including Dallas-Fort Worth, Houston, San Antonio and Austin. "Growth provides access and access changes lives," said Grant Davies, CEO of Solis Mammography. "Our goal with every market and every community we enter is to advance our mission of early breast cancer detection, and we never want to lose sight of that. We know that when we change the way mammography is experienced through innovative practices, improved technology and patient-centered care, we can make a difference. We hope to build on Avestēe's more than 10-year history of providing an expert and personalized approach to women's imaging." Founded in 2013 by Suzanne Dabbous, MD, Avestēe has provided patients with expert radiologic interpretations in a compassionate, non-clinical environment. The practice has six locations in San Antonio, Boerne and Spring Branch, Texas. "Avestēe Women's Imaging Centers' commitment to expert, compassionate care aligns perfectly with Solis Mammography's mission and vision for the future. We are excited to continue growing by joining the Solis family, a national leader in breast imaging and women's health innovation," said Dr. Dabbous. Solis Mammography combines clinical excellence with cutting-edge AI-screening technology to deliver exceptional patient-centered care – a tradition maintained for 40 years. The acquisition of Avestēe Women's Imaging Centers expands the company's footprint into its 19th major market. About Solis Mammography Solis Mammography, a premier women's health company and the nation's largest independent provider of specialized breast health services, has been dedicated to elevating mammography services and maintaining breast health and peace of mind for 40 years. Headquartered in Addison, Texas, Solis Mammography operates more than 141 centers in 19 major markets, including Dallas-Fort Worth, Houston, Austin, San Antonio, South Louisiana, Utah, Denver, Phoenix, Tucson, the greater Philadelphia area, Columbus, Nashville, North Carolina, Virginia, Miami, Ft. Lauderdale, and Gainesville, Florida. Its affiliated brand, Washington Radiology, operates centers in Washington, D.C., Maryland, and Virginia. Solis Mammography is pioneering a boutique-style retail healthcare experience. The company operates both wholly owned centers and multiple successful joint venture partnerships with large hospital systems and prominent medical and academic institutions. View original content to download multimedia: https://www.prnewswire.com/news-releases/solis-mammography-announces-acquisition-of-aveste-womens-imaging-centers-in-san-antonio-302332883.html SOURCE Solis Mammography Copyright © 2024 PR Newswire Association LLC. All Rights Reserved.

SAN JOSE – The San Jose Sharks activated center Nico Sturm off injured reserve Monday and made room for him on the 23-man roster by assigning defenseman Jack Thompson to the AHL’s San Jose Barracuda. The transactions mean that the Sharks currently have 14 forwards, six defensemen, and three goalies: Mackenzie Blackwood, Vitek Vanecek, and rookie Yaroslav Askarov. Sturm’s return to the Sharks’ active roster was believed to be imminent after he showed signs of improvement last week and practiced with the team on Sunday. He also took part in the Sharks’ morning skate on Monday, when he was officially considered a game-time decision by coach Ryan Warsofsky. The Sharks play the Los Angeles Kings on Monday night in the second game of a four-game homestand. Warsofsky did not say who his starting goalie would be. Warsofsky said he had a few players who were “nicked up” and considered game-time decisions, although it would be a surprise not to see Sturm, a mainstay as the Sharks’ fourth-line center, play against the Kings. Sturm, injured in the Sharks’ game earlier this month against the New York Rangers, is the Sharks’ faceoff leader by percentage and is one of the team’s leading penalty-killing forwards. Thompson has been on the Sharks’ roster for almost the entire season and played in 13 of the team’s 23 games. His five points are third-most among all Sharks defensemen, as he’s averaged just under 16 minutes of ice time per game. The Sharks have had three goalies on their roster since Nov. 18, when they recalled Askarov from the Barracuda. At the time, Vanecek was considered day-to-day with an upper-body injury, but Vanecek backed up Blackwood on Saturday in the Sharks’ 4-2 loss to the Buffalo Sabres. Askarov made his Sharks debut on Thursday, making 29 saves in a 3-2 shootout loss to the St. Louis Blues. It’s unclear how long the Sharks plan to keep three goalies on their active roster. Both Blackwood and Vanecek are pending unrestricted free agents, and speculation is that one could be dealt to another team before the NHL trade deadline on March 7. Kevin Weekes of ESPN and the NHL Network posted on the social media platform X on Monday that the Carolina Hurricanes “are exploring potential goalie options in the market.” Frederik Andersen is out eight to 12 weeks after knee surgery, and Pyotr Kochetkov left Saturday’s game at Columbus after colliding with defenseman Sean Walker. Kochetkov is now in concussion protocol.Virgin Hotels Las Vegas’ top two executives were granted full control of casino operations amid an intensifying labor dispute with striking workers, and, with contract negotiations at an apparent impasse, union members took advantage of Wednesday’s public meeting to urge Nevada gaming regulators to scrutinize ownership’s ability to meet employee demands. The Nevada Gaming Control Board gave the greenlight Wednesday morning to a newly formed entity — C&C 4455 — to take over the day-to-day casino operations of the off-Strip casino property. C&C 4455 is comprised of Cliff Atkinson and Chad Konrad, the property’s president and chief financial officer, respectively. Atkinson will assume the role of chief executive officer while Konrad will continue as CFO, a position he has held at the property since it was known as the Hard Rock Hotel. The Nevada Gaming Commission must approve the changes before they become final. The two veteran gaming executives told the NGCB that with Mohegan Gaming’s departure as the casino operator, friction points separating Virgin’s hotel, gaming and resort operations would be removed, thereby creating a more streamlined guest experience. The goal, they said, is stability. “Since reopening (as Virgin Hotels Las Vegas in 2021), the property has struggled. I think that’s pretty public and well known,” Atkinson said Wednesday morning in Las Vegas. “The deal with Mohegan simply did not work....The reason we are here (seeking approval of C&C 4455) is to successfully turn the gaming operations around.” Atkinson outlined a long-term plan for Virgin’s success that includes an appeal to locals, the activation of “dead spaces” on the property by bringing in new entertainment and amenities for guests, and the creation of a new customer loyalty program. He said there was an opportunity to return value to the Las Vegas casino market. “We both have a similar belief in the property, in the casino specifically and in our ability to really drive this casino from a performance standpoint forward and to keep this thing running, keep the doors open on this thing,” Konrad told the three-member gaming board. Culinary, Virgin unable to come to terms Prior to testimony from Atkinson and Konrad, members of Culinary Union Local 226 implored the board to question the gaming executives about the property owner’s financial situation, which they believe is being misrepresented as a means to avoid negotiating in good faith. Culinary 226 has engaged in an open-ended strike that began on Nov. 15 , making it the longest labor demonstration in recent memory. Ted Pappageorge, the union’s treasurer and secretary, told the board that Virgin employees have been working under contract conditions that expired 18 months ago. The union is reportedly seeking a new contract comparable to those offered at other off-Strip casinos, such as Westgate, Sahara, Rio and The Strat. Despite multiple negotiations, the two sides have been unable to come to terms. “Unfortunately, we have a company that is unwilling to settle the standards that we have negotiated in Las Vegas. They are the final remaining company that has not come to the table with a fair contract,” Papageorge said. The union believes that Virgin’s ownership is more than capable of meeting contract demands. The property’s ownership group includes a multi-billion-dollar Canadian-based pension fund, a private equity firm called Juniper Capital Management and British billionaire Sir Richard Branson’s Virgin Group. Union member and Virgin employee Paul Catha said Nevada has a “complicated relationship” with billionaire institutions and individuals, and questioned why no one from the ownership group was present Wednesday to speak about the newly formed casino operation entity. “Why would Nevada not require the owners of Virgin Las Vegas to be included in a review of the resort’s own licensed casino operation application?” Catha asked. “We believe Nevada gaming regulators should ask broader and deeper questions about sources of funds and ultimate control at Virgin Las Vegas.” NGCB Chair Kirk Hendrick indirectly addressed those concerns during the testimony of Atkinson and Konrad, alluding to an investigative document that was “a couple of inches thick,” suggesting that regulators had conducted due diligence on both the executives and the ownership group. For now, the union’s strike will continue. “These companies have extremely deep pockets,” Papageorge said of Virgin’s ownership group. “So the idea that these Canadian economic entities would come to Las Vegas to try to destroy our standards of living that we’ve worked for decades to build is just unacceptable...and if they don’t agree to Vegas standards, (they should) go back to Canada.” The casino dismissed the union’s talking points. “The Culinary Workers Union Local 226 continues to bargain in bad faith – repeatedly refusing to engage in meaningful negotiations with us since January 2024 – and nothing has changed. Despite Virgin Hotels Las Vegas agreeing to many of the Culinary Union leadership’s demands and showing flexibility on critical sticking points, the Culinary Union has not seriously countered any of our economic proposals, nor even brought our latest offer to their members for a formal vote,” the casino said in a statement, later adding that union “leadership’s current demand is not financially sustainable for Virgin Hotels Las Vegas, and we will not agree to the same contract that led to layoffs at other properties. Virgin Hotels Las Vegas remains focused on reaching a reasonable agreement that secures a brighter future for all of our 1,710 team members and their families.”

Financial Crime Weekly: CEO Sentenced To 51 Months In Prison, Kiromic BioPharma Charged With Failure To Disclose Material Information

Kia, Toyota, Changan Lead Race For 2024 Nigeria’s Car Of The Year AwardHow major US stock indexes fared Friday, 12/13/2024

US stocks surge to records, shrugging off upheaval in South Korea, FranceThanksgiving Travel Latest: Airport strike, staff shortages and weather could impact holiday travel

Jessica Tisch trades NYC's 'war on rats' to become NYPD's 'battle-tested' leader

NEW YORK (AP) — U.S. stock indexes drifted amid mixed trading Monday, ahead of this week’s upcoming meeting by the Federal Reserve that could set Wall Street’s direction into next year. The S&P 500 rose 0.4%, coming off its first losing week in the last four . The Nasdaq composite climbed 1.2% to a record, while the Dow Jones Industrial Average was a laggard and fell 110 points, or 0.3%. Broadcom leaped 11.2% to help lead the S&P 500 for a second straight day after delivering a profit report last week that beat analysts’ expectations. The technology company is riding a wave of enthusiasm about its artificial-intelligence offerings in particular. The market’s main event, though, will arrive on Wednesday when the Federal Reserve will announce its last move on interest rates for the year. The widespread expectation is that it will cut its main rate for a third straight time, as it tries to boost the slowing job market after getting inflation nearly all the way down to its target of 2%. The question is how much more it will cut rates next year, and Fed officials will release projections for where they see the federal funds rate ending 2025, along with other economic indicators, once their meeting concludes. Fed Chair Jerome Powell will also answer questions in a press conference following the meeting. For now, the general expectation among traders is that the Fed may cut a couple more times in 2025, according to data from CME Group. But such expectations have been shrinking following reports suggesting inflation may be tougher to get all the way down to 2% from here. Besides last month’s slight acceleration in inflation, another worry is that President-elect Donald Trump’s preferences for tariffs and other policies could lead to higher inflation down the line. Goldman Sachs economist David Mericle has dropped his earlier forecast of a cut by the Fed in January, for example. Beyond the possibility of tariffs, he said Fed officials may also want to slow their cuts because of uncertainty about exactly how low rates need to go so that they no longer press the brakes on the economy. Expectations for a series of cuts to rates by the Fed have been one of the main reasons the S&P 500 has set an all-time high 57 times so far this year and is heading for one of its best years of the millennium . The economy has held up better than many feared, continuing to grow even after the Fed hiked the federal funds rate to a two-decade high in hopes of grinding down on inflation, which topped 9% two summers ago. On Wall Street, MicroStrategy jumped as much as 7% during the day as it continues to benefit from the surging price for bitcoin , which set another all-time high. But its stock ended the day down by les than 0.1% after bitcoin’s price pulled back below $106,000 after setting a record above $107,700, according to CoinDesk. The software company has been building its hoard of the cryptocurrency, and its stock price has more than sextupled this year. It will also soon join the Nasdaq 100 index. Bitcoin’s price has catapulted from roughly $44,000 at the start of the year, riding a recent wave of enthusiasm that Trump will create a system that’s more favorable to digital currencies . Honeywell rose 3.7% after saying it’s still considering a spin-off or sale of its aerospace business, as part of a review of its overall business. It said it plans to give an update with the release of its fourth-quarter results. They helped offset a drop for Nvidia, whose chips are powering much of the world’s move into AI. Its stock fell 1.7%. Because it’s grown so massive, with a total value topping $3 trillion, it was the single heaviest weight on the S&P 500. All told, the S&P 500 rose 22.99 points to 6,074.08. The Dow Jones Industrial Average fell 110.58 to 43,717.48, and the Nasdaq composite rose 247.17 to 20,173.89. In the bond market, Treasury yields held relatively steady. The yield on the 10-year Treasury edged down to 4.39% from 4.40% late Friday. The two-year yield, which more closely tracks expectations for the Fed, eased to 4.24% from 4.25%. In stock markets abroad, indexes fell modestly across much of Europe and Asia. They sank 0.9% in Hong Kong and 0.2% in Shanghai after China reported lackluster economic indicators for November despite attempts to strengthen the world’s second-largest economy. South Korea’s Kospi fell 0.2% as law enforcement authorities pushed to summon impeached President Yoon Suk Yeol for questioning over his short-lived martial law decree, and the Constitutional Court met to discuss whether to remove him from office or reinstate him. ___ AP Business Writer Elaine Kurtenbach contributed. Stan Choe, The Associated Press

US stocks surge to records, shrugging off upheaval in South Korea, FranceMINNEAPOLIS--(BUSINESS WIRE)--Dez 16, 2024-- HistoSonics , Entwickler und Hersteller des Edison® Histotripsy Systems, gab heute bekannt, dass die ersten Patienten mit Pankreastumoren erfolgreich in der von dem Unternehmen gesponserten GANNON-Studie behandelt wurden. Die Machbarkeitsstudie soll die Sicherheit der Histotripsie, einer neuartigen nicht-invasiven Technologie, die gezielt Tumorgewebe mit fokussiertem Ultraschall zerstört, bei bis zu 30 Patienten mit inoperablen Pankreas-Adenokarzinom-Tumoren untersuchen, bei denen eine inoperable lokal fortgeschrittene Erkrankung (Stadium 3) diagnostiziert wurde oder bei denen sich eine geringe Anzahl von Tumoren auf andere Körperteile ausgebreitet hat (Stadium 4). Diese Pressemitteilung enthält multimediale Inhalte. Die vollständige Mitteilung hier ansehen: https://www.businesswire.com/news/home/20241216108664/de/ Die GANNON-Studie wird am Sant Pau Hospital in Barcelona, Spanien, unter der Leitung von Dr. Santiago Sánchez Cabús, klinischer Leiter der Hepatopankreatobiliären Chirurgie am Hospital de Sant Pau und Professor für Chirurgie an der Autonomen Universität Barcelona, durchgeführt. Bauchspeicheldrüsentumore gehören zu den am schwierigsten zu behandelnden Tumoren. Jedes Jahr sind weltweit über 510.000 Menschen davon betroffen, und allein in den USA werden im Jahr 2024 schätzungsweise 66.440 Patienten diagnostiziert1,2. Mit der höchsten Sterblichkeitsrate aller wichtigen Tumorarten sind Tumore der Bauchspeicheldrüse derzeit die dritthäufigste Ursache für tumorbedingte Todesfälle in den Vereinigten Staaten, nach Lungen- und Darmkrebs, und es wird erwartet, dass sie bis 2030 zur zweithäufigsten Ursache werden2. Angesichts einer relativen Fünf-Jahres-Überlebensrate von 13 % über alle Stadien des Krankheitsverlaufs hinweg und begrenzter chirurgischer Möglichkeiten für die meisten Patienten sind neue Behandlungsmethoden wie die Histotripsie dringend erforderlich. Weniger als 20 % der Patienten, die an einem Pankreastumor leiden, kommen aufgrund des Fortschreitens der Krankheit zum Zeitpunkt der Diagnose für eine Operation in Frage. Pankreastumore sind oft von dichtem, undurchdringlichem fibrotischem Gewebe umgeben, das die Wirksamkeit systemischer oder pharmakologischer Therapien einschränkt, da es nicht in der Lage ist, die Tumorzellen effektiv zu erreichen und anzugreifen.2,3 „Die Histotripsie hat das Potenzial, die Behandlung von Patienten mit Bauchspeicheldrüsentumoren zu revolutionieren, die bisher mit herkömmlichen Ansätzen als unbehandelbar galten. Ihr neuartiger Wirkmechanismus zielt sowohl auf den Tumor als auch auf das umgebende fibrotische Gewebe ab und bietet neue Hoffnung für Patienten mit fortgeschrittener Erkrankung, die die Mehrheit der Fälle ausmachen“, so Dr. Joan Vidal-Jove, medizinische Direktorin von HistoSonics. „Die meisten Patienten mit Bauchspeicheldrüsentumoren haben nur begrenzte Behandlungsmöglichkeiten und kommen aufgrund des fortgeschrittenen Krankheitsstadiums nicht für eine Operation in Frage“, so Mike Blue, CEO und Präsident von HistoSonics. „Wir glauben, dass die Histotripsie eine nicht-invasive Option zur Behandlung von Tumoren bietet, die bisher als unheilbar galten", so Mike Blue, CEO und Präsident von HistoSonics. „Unser Ziel ist es, das Potenzial der Histotripsie bei verschiedenen Tumorarten zu erweitern und die Ergebnisse für Patienten und Familien erheblich zu verbessern. Unsere ersten Forschungsergebnisse aus der GANNON-Studie werden uns und unsere Partnerärzte dabei helfen, die Histotripsie zu optimieren, um das Leben der Patienten erheblich zu verbessern.“ Die Verwendung des Edison-Systems bei Bauchspeicheldrüsenanwendungen ist auf Forschungszwecke beschränkt. Über das Edison® System Das Edison System ist für die nicht-invasive mechanische Zerstörung von Lebertumoren vorgesehen, einschließlich der teilweisen oder vollständigen Zerstörung von inoperablen Lebertumoren durch Histotripsie. Die FDA hat das Edison-System nicht für die Behandlung von Krankheiten, einschließlich, aber nicht beschränkt auf Krebs, oder für spezifische Krebsergebnisse (wie lokale Tumorprogression, 5-Jahres-Überlebensrate oder Gesamtüberlebensrate) bewertet. Das System sollte nur von Ärzten verwendet werden, die eine von HistoSonics durchgeführte Schulung absolviert haben, und seine Verwendung sollte sich nach dem klinischen Urteil eines entsprechend ausgebildeten Arztes richten. Eine vollständige Liste der Warnhinweise und Vorsichtsmaßnahmen sowie eine Zusammenfassung der Ergebnisse klinischer Studien, einschließlich der gemeldeten unerwünschten Ereignisse, finden Sie in der Gebrauchsanweisung des Geräts. Über HistoSonics HistoSonics ist ein in Privatbesitz befindliches Medizintechnikunternehmen, das eine nicht-invasive Plattform und eine proprietäre Schallstrahltherapie auf Basis der wissenschaftlichen Erkenntnisse der Histotripsie entwickelt. Es handelt sich dabei um einen neuartigen Wirkmechanismus, bei dem fokussierter Ultraschall eingesetzt wird, um unerwünschtes Gewebe und Tumore mechanisch zu zerstören und zu verflüssigen. Derzeit konzentriert sich das Unternehmen auf die Kommerzialisierung seines Edison-Systems in den USA und ausgewählten globalen Märkten für die Behandlung der Leber, während gleichzeitig die Anwendung der Histotripsie auf andere Organe wie Niere, Bauchspeicheldrüse und weitere Organe erweitert wird. HistoSonics unterhält Niederlassungen in Ann Arbor, Michigan und Minneapolis, Minnesota. Weitere Informationen zur GANNON-Studie finden Sie unter NCT06282809 unter GANNON Trial Information auf ClinicalTrials.gov . Informationen zum Edison Histotripsy System finden Sie unter: www.histosonics.com/ . Patientenbezogene Informationen finden Sie unter: www.myhistotripsy.com/ . 1Globocan 2022: https://gco.iarc.fr/today/en/fact-sheets-cancers 2Quelle für Statistiken: American Cancer Society: Cancer Facts & Figures 2024 and Pancreatic Treatment Options 3Norton J, Foster D, Chinta M, Titan A, Longaker M. Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment. Cancers. 2020; 12(5):1347. Die Ausgangssprache, in der der Originaltext veröffentlicht wird, ist die offizielle und autorisierte Version. Übersetzungen werden zur besseren Verständigung mitgeliefert. Nur die Sprachversion, die im Original veröffentlicht wurde, ist rechtsgültig. Gleichen Sie deshalb Übersetzungen mit der originalen Sprachversion der Veröffentlichung ab. Originalversion auf businesswire.com ansehen: https://www.businesswire.com/news/home/20241216108664/de/ CONTACT: Josh King Vice President of Global Market Access Joshua.king@histosonics.com 608-332-8124Kimberly Ha KKH Advisors kimberly.ha@kkhadvisors.com 917-291-5744 KEYWORD: MINNESOTA SPAIN NORTH AMERICA UNITED STATES ASIA PACIFIC EUROPE INDUSTRY KEYWORD: MEDICAL DEVICES HOSPITALS CLINICAL TRIALS HEALTH TECHNOLOGY BIOTECHNOLOGY OTHER HEALTH RADIOLOGY HEALTH ONCOLOGY SOURCE: HistoSonics Copyright Business Wire 2024. PUB: 12/16/2024 06:34 PM/DISC: 12/16/2024 06:35 PM http://www.businesswire.com/news/home/20241216108664/de

Vireon Hydrogen Oy awarded a grant of 3,8M Euros from Business Finland to build a 5MW electrolyzer facility in Jyväskylä, Finland Vireon Hydrogen Oy has been awarded a grant of 3.8 million Euros from Business Finland to build a 5MW electrolyzer facility in Jyväskylä, Finland. This groundbreaking project marks a significant milestone in the development of the Finnish hydrogen economy and the advancement of green hydrogen as a key enabler of zero-emission solutions. Managing Director of Vireon, said : “This grant will allow us to complete the green hydrogen value chain in Jyväskylä, in collaboration with our trusted partners at CEFMOF.” Vireon is already in the process of establishing the Jyväskylä Hydrogen Hub. Phase one involves building a hydrogen refueling station for heavy-duty transport, partly funded by a prior EU grant to the company. The first users are already confirmed, including five hydrogen-powered buses set to enter regular bus traffic in Jyväskylä. The station is scheduled to be operational by 2025. Phase two will expand the hub with local hydrogen production, supported by the new grant. The electrolyzer will be built on the same site as the refueling station, with groundwork starting immediately to accelerate implementation. With a 5MW electrolyzer, Vireon will be able to produce approximately 700 tons of green hydrogen annually. This hydrogen will reduce emissions in Finland’s transport sector and will be sold to various heavy transport operators through Vireon’s Finnish refueling network. Vireon has secured substantial national and EU funding for hydrogen production and refueling infrastructure across Finland, Denmark, Norway, and Sweden. This latest grant solidifies its leadership in driving Europe’s transition to a sustainable, zero-emission future. Additionally, the Finnish Energy Authority has confirmed Vireon as the first voluntary distributor of RFNBO fuels under Finland’s distribution obligation. Effective January 1, 2025, this recognition allows Vireon to supply RFNBO fuels across the country, supporting Finland’s shift toward clean energy. the latest news shaping the hydrogen market at Vireon Hydrogen Oy awarded a grant of 3,8M Euros from Business Finland to build a 5MW electrolyzer facility in Jyväskylä, Finland, HØST PtX Esbjerg secures environmental approvals – development of installing up to 1 GW of electrolyser capacity The Danish Environmental Agency has granted the Project HØST PtX Esbjerg the primary environmental... IMI to supply groundbreaking German hydrogen research project with PEM electrolyser The project, which will be delivered by the Fraunhofer-Institution for Energy Infrastructures and Geothermal Systems in Zittau... Hygreen Energy Delivers 25MW Electrolyzer System to Largest Hydrogen Project in Shandong Beijing, China – December 10, 2024 – Hygreen Energy, a global electrolyzer manufacturer and hydrogen technology developer...

Thanksgiving Travel Latest: Airport strike, staff shortages and weather could impact holiday travel

Previous:
Next: play slot game online